Bionest team member Rachel Laing recently contributed to a feature in the January issue of PharmaVoice on the growing role and prominence of biomarker strategies in drug development and commercialization. In addition to helping to better identify those patients who will respond to a particular therapy, a biomarker strategy enables companies to differentiate their product and...
First of all, we at Bionest want to wish you a very happy, healthy, and prosperous new year. And we look forward to speaking to many of you in person during JP Morgan week in San Francisco! Another year ended. Another begun. In the time-honored tradition of year-end wrap-ups and new year’s predictions, we...